Literature DB >> 9924071

Intravenous beta blockade in acute myocardial infarction. Doubts exist about external validity of trials of intravenous beta blockade.

K L Woods, D Ketley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9924071      PMCID： PMC1114792          DOI： 10.1136/bmj.318.7179.328b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Intravenous beta blockade in acute myocardial infarction. Should be used in combination with thrombolysis.

Authors:  A Owen
Journal:  BMJ       Date:  1998-07-25

2.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.

Authors:  R Roberts; W J Rogers; H S Mueller; C T Lambrew; D J Diver; H C Smith; J T Willerson; G L Knatterud; S Forman; E Passamani
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

3.  Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group.

Authors:  K L Woods; D Ketley; A Lowy; A Agusti; C Hagn; R Kala; N B Karatzas; A Leizorowicz; A Reikvam; J Schilling; R Seabra-Gomes; D Vasiliauskas; L Wilhelmsen
Journal:  Eur Heart J       Date:  1998-01       Impact factor: 29.983

4.  Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

5.  What happened to intravenous atenolol in acute myocardial infarction?

Authors:  P Sleight
Journal:  Cardiology       Date:  1994       Impact factor: 1.869
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.